WLA PHarmaSE exclusive network’s vision is to establish a worldwide exclusive network ,which can handle pharmaceutical products according to GDPor CEIV certification procedure. We would like to be able to serve international pharmaceutical companies on a global scale!
We want o provide a globally recognized, ethically-led quality standard for the protection and movement of healthcare products around the world, and to promote WLA PHarmaSE / Good Distribution Practice (GDP) and total quality amongst its staff members and licensees.
The global pharmaceutical industry operates at a high level of quality assurance, achieving its pharmaceutical quality objectives by observing GMP (Good Manufacturing Practice) to manufacture pharmaceutical and related products. This level of quality needs to be maintained throughout the transportation process with GDP certified members or agents so that authorized pharmaceutical and related products are distributed to manufacturers, retail pharmacists and other persons/companies entitled to sell pharmaceutical and related products to the general public, without any alteration of their properties.
Pharma warehouses go to great lengths to protect manufactured products whilst in their care, but once they are handed over to a freight forwarder for movement to the main distributor or end user, maybe in another country, such products can be exposed to extreme temperatures and handling procedures which can in turn compromise their integrity, and in the worst cases rendering them worthless. It is with this in mind WLA PHarmaSE has written a guide for its own part in the supply chain, namely Good Distribution Practice (GDP). With the adoption of its GDP system amongst its chosen partners, WLA PHarmaSE is positioning itself to provide a global system to protect these products in between the manufacturer and the end user.
